Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Assertio Therapeutics, Inc | a2202625z10-k.htm |
| EX-32.1 - EX-32.1 - Assertio Therapeutics, Inc | a2202625zex-32_1.htm |
| EX-31.2 - EX-31.2 - Assertio Therapeutics, Inc | a2202625zex-31_2.htm |
| EX-23.1 - EX-23.1 - Assertio Therapeutics, Inc | a2202625zex-23_1.htm |
| EX-31.1 - EX-31.1 - Assertio Therapeutics, Inc | a2202625zex-31_1.htm |
QuickLinks -- Click here to rapidly navigate through this document
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Depomed, Inc. (the "Company") on Form 10-K for the period ending December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Tammy L. Cameron, Interim Principal Accounting Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: March 16, 2011 | ||
/s/ TAMMY L. CAMERON Tammy L. Cameron Vice President, Finance and Principal Accounting Officer |
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002